| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 11/05/2008 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 11/05/2008 | P | 6,100 | A | $2.49 | 155,881 | D | |||
| Common Stock | 11/05/2008 | P | 23,900 | A | $2.5 | 179,781 | D | |||
| Common Stock | 750 | I | By IRA | |||||||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| 1999 July Option (Right to Buy) | $11.13 | (1) | 07/28/2009 | Common Stock | 17,700 | 17,700 | D | ||||||||
| 2004 March Option (Right to Buy) | $12.01 | (2) | 03/03/2014 | Common Stock | 66,666 | 66,666 | D | ||||||||
| 2005 February Option (Right to Buy) | $10.52 | (2) | 02/16/2015 | Common Stock | 60,000 | 60,000 | D | ||||||||
| 2006 February Option (Right to Buy) | $7.93 | (2) | 02/22/2016 | Common Stock | 55,000 | 55,000 | D | ||||||||
| 2006 February Restricted Units | $0.00(3) | (3) | (3) | Common Stock | 18,334 | 18,334 | D | ||||||||
| 2007 January Restricted Units | $0.00(3) | (3) | (3) | Common Stock | 33,600 | 33,600 | D | ||||||||
| 2007 March Option (Right to Buy) | $6.6 | (2) | 03/01/2017 | Common Stock | 140,000 | 140,000 | D | ||||||||
| 2007 March Restricted Units | $0.00(3) | (3) | (3) | Common Stock | 40,000 | 40,000 | D | ||||||||
| 2007 Performance Based Restricted Units (N) | $0.00(4) | (4) | (4) | Common Stock | 90,000 | 90,000 | D | ||||||||
| 2008 March Option (Right to Buy) | $4.94 | (2) | 03/06/2018 | Common Stock | 450,000 | 450,000 | D | ||||||||
| 2008 March Restricted Units | $0.00(3) | (3) | (3) | Common Stock | 122,500 | 122,500 | D | ||||||||
| Explanation of Responses: |
| 1. These derivative securities (stock options) vested ratably on each of the first, second, and third anniversaries of the date of grant. |
| 2. These derivative securities (stock options) vest ratably on each of the first, second and third anniversaries of the date of grant. |
| 3. These restricted units vest ratably on each of the first, second and third anniversaries of the date of grant. Restricted Units are settled in shares of the Company's common stock upon vesting. |
| 4. On the third anniversary of the date of grant, these restricted units vest conditionally based on the average of the closing price of the company's common stock on the last 40 trading days of 2009 ("Stock Price") as follows: 30,000 restricted units vest if the Stock Price is $6.75 or less; 60,000 restricted units vest if the Stock Price is $8.50; and 90,000 restricted units if the Stock Price is $10.25 or greater. Straight-line interpolation will be used to determine the number of restricted units vesting for Stock Prices between the threshold prices stated. Restricted units are settled in shares of the Company's common stock upon vesting. |
| Remarks: |
| /s/ Newman, Stephen L. | 11/05/2008 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||